Naloxone Continuous Infusion Protocol
For opioid overdose requiring prolonged reversal, initiate a continuous naloxone infusion at two-thirds of the effective bolus dose per hour after achieving adequate respiratory function with initial boluses.
Initial Bolus Dosing
Start with standard naloxone boluses to reverse respiratory depression 1:
- Adults: 0.4-2 mg IV initially
- Children: 0.01 mg/kg IV initially
- Neonates: 0.01 mg/kg IV, IM, or SC
Repeat boluses every 2-3 minutes until adequate ventilation is achieved. If no response after 10 mg total, question the diagnosis of opioid toxicity 1.
When to Start a Continuous Infusion
Consider continuous infusion when:
- Repeated boluses are required to maintain adequate ventilation
- Long-acting opioids are involved (methadone, extended-release formulations, fentanyl)
- Respiratory depression recurs despite multiple boluses
- Patient requires ongoing monitoring in ICU setting
Critical caveat: The duration of action of many opioids exceeds naloxone's half-life, necessitating either repeated boluses or continuous infusion 1.
Infusion Preparation and Dosing
Standard concentration: Add 2 mg naloxone to 500 mL normal saline or 5% dextrose = 0.004 mg/mL (4 mcg/mL) 1.
Infusion rate calculation: Use two-thirds of the effective bolus dose per hour 2.
- If 2 mg bolus achieved reversal → infuse at approximately 1.3-1.5 mg/hour
- If 4 mg bolus achieved reversal → infuse at approximately 2.5-3 mg/hour
The classic dosing nomogram from pharmacokinetic studies demonstrates that this two-thirds rule maintains plasma naloxone levels equal to or greater than levels present 30 minutes after the initial bolus 2.
Alternative simplified approach: Start at 0.4 mg/hour and titrate to patient response 3. In pediatrics, 0.4 mg/hour (approximately 27 mcg/kg/hour for average-sized children) has been used safely 3.
Titration and Monitoring
- Titrate the infusion rate based on respiratory status - aim for adequate spontaneous ventilation without precipitating severe withdrawal 1
- Monitor respiratory rate, oxygen saturation, and level of consciousness continuously
- Keep patient under continued surveillance in monitored setting
- Adjust rate up if respiratory depression recurs; adjust down if withdrawal symptoms emerge
Important: Avoid over-reversal. Larger than necessary doses cause significant analgesia reversal, hypertension, and can precipitate acute withdrawal with nausea, vomiting, and circulatory stress 1.
Duration and Stability
- Use prepared infusion within 24 hours; discard any remaining solution after 24 hours 1
- Continue infusion until risk of re-sedation has passed (typically determined by the half-life of the ingested opioid)
- For methadone: may require 24-72 hours of infusion
- For fentanyl analogs: duration varies but often requires extended monitoring
Compatibility and Preparation
Do not mix naloxone with 1:
- Preparations containing bisulfite or metabisulfite
- Long-chain or high molecular weight anions
- Solutions with alkaline pH
Inspect solution visually for particulate matter and discoloration before administration 1.
Emerging Alternative: Buprenorphine Transition
Recent evidence suggests that 16 mg sublingual buprenorphine can successfully replace a continuous naloxone infusion in select patients, allowing discontinuation without recurrent respiratory depression 4. This approach:
- Reduces hospital resource utilization
- Initiates medication for opioid use disorder
- Leverages buprenorphine's long-acting partial agonist effects to prevent re-sedation
This strategy should be considered after consultation with toxicology or addiction medicine specialists 4.
Key Clinical Pitfalls
- Underestimating opioid duration: Fentanyl analogs and methadone have prolonged effects requiring extended infusions
- Premature discontinuation: Stopping infusion too early leads to recurrent respiratory depression
- Over-reversal: Excessive naloxone precipitates severe withdrawal and complications
- Inadequate monitoring: Patients require continuous cardiorespiratory monitoring throughout infusion
- Forgetting the 24-hour stability limit: Prepared solutions must be discarded after 24 hours 1
Context: Cardiac Arrest vs Respiratory Arrest
Critical distinction: In confirmed cardiac arrest, standard CPR takes absolute priority over naloxone administration - there is no proven benefit of naloxone in cardiac arrest 5. However, for respiratory arrest with definite pulse, naloxone administration alongside standard BLS/ALS care is reasonable and recommended 5.